Ken Griffin Smith & Nephew PLC Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$25.36 - $28.88 $380,400 - $433,200	15,000 Added 133.93%	26,200 $664,000
Q4 2023 Feb 14, 2024	SELL	$21.55 - $27.43 $23,705 - $30,173	-1,100 Reduced 8.94%	11,200 $305,000
Q3 2023 Nov 14, 2023	BUY	$24.33 - $31.28 $38,928 - $50,048	1,600 Added 14.95%	12,300 $304,000
Q2 2023 Aug 14, 2023	BUY	$28.08 - $32.7 $123,551 - $143,880	4,400 Added 69.84%	10,700 $345,000
Q1 2023 May 15, 2023	BUY	$27.29 - $29.4 $111,889 - $120,540	4,100 Added 186.36%	6,300 $175,000

Q4 2022 Feb 14, 2023	SELL	$22.3 - $27.91 $925,450 - $1.16 Million	-41,500 Reduced 94.97%	2,200 $59,000
Q3 2022 Nov 14, 2022	BUY	$12.1 - $29.35 $528,770 - $1.28 Million	43,700 New	43,700 $1.02 Million

222

31.5M

2.8K

51.7K

Ticker SNN
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 435,348,000
Market Cap $11.8B
Description
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.